MEDIROM Healthcare Technologies Inc. Announces Pricing of Public Offering
Summary
The Offering is expected to close on December 11, 2024, subject to the satisfaction of customary closing conditions.MEDIROM intends to use the proceeds for working capital and general corporate purposes, which may include investments, acquisitions, or strategic collaborations to expand its customer base, as well as marketing of new services.ThinkEquity is acting as sole book-running manager for the offering.A registration statement on Form F-1 (File No. Copies of the final prospectus may be obtained from ThinkEquity, 17 State Street, 41st Floor, New York, New York 10004.This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.MEDIROM, a holistic healthcare company, operates over 300 wellness salons across Japan, Re.Ra.Ku\xae being its leading brand, and provides healthcare services. In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. In some cases, forward-looking statements can be identified by terms such as may, will, should, design, target, aim, hope, expect, could, intend, plan, anticipate, estimate, believe, continue, predict, project, potential, goal, or other words that convey the uncertainty of future events or outcomes. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROMs control and which could, and likely will, affect actual results, levels of activity, performance or achievements.